We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

55 hedge funds and large institutions have $35.8M invested in Mustang Bio in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 11

56% more call options, than puts

Call options by funds: $306K | Put options by funds: $196K

1% more capital invested

Capital invested by funds: $35.3M → $35.8M (+$487K)

0% more funds holding

Funds holding: 55 → 55 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

0.01% less ownership

Funds ownership: 0.04% → 0.03% (-0.01%)

Holders
55
Holders Change
–
Holders Change %
0%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
22
Reduced
11
Closed
7
Calls
$306K
Puts
$196K
Net Calls
+$110K
Net Calls Change
-$136K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$769K
2
OAM
Oxford Asset Management
United Kingdom
+$556K
3
BlackRock
BlackRock
New York
+$481K
4
BCM
Bridgeway Capital Management
Texas
+$215K
5
Renaissance Technologies
Renaissance Technologies
New York
+$197K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$10.3M
2
6CM
683 Capital Management
New York
-$504K
3
SSA
Schonfeld Strategic Advisors
New York
-$492K
4
N
Nuveen
North Carolina
-$254K
5
FWM
Frontier Wealth Management
Missouri
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
QOP
26
Quinn Opportunity Partners
Virginia
$139K -$4.58K -2 -4%
Citadel Advisors
27
Citadel Advisors
Florida
$129K +$20.6K +9 +27%
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$120K +$2.29K +1 +3%
Barclays
29
Barclays
United Kingdom
$114K +$43.5K +19 +106%
ARTA
30
A.R.T. Advisors
New York
$107K -$9.16K -4 -10%
PPA
31
Parametric Portfolio Associates
Washington
$75K -$2.29K -1 -4%
AIG
32
American International Group
New York
$71K – – –
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$67K – – –
VOYA Investment Management
34
VOYA Investment Management
Georgia
$64K +$4.58K +2 +11%
IWM
35
IHT Wealth Management
Illinois
$63K +$13.7K +6 +40%
FAM
36
Fenimore Asset Management
New York
$61K – – –
KWM
37
Kingsview Wealth Management
Oregon
$61K +$45.8K +20 New
Millennium Management
38
Millennium Management
New York
$48K -$52.7K -23 -59%
CL
39
CSS LLC
Illinois
$43K – – –
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$43K +$32.1K +14 New
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$41K – – –
Envestnet Asset Management
42
Envestnet Asset Management
Illinois
$41K – – –
SAG
43
Spotlight Asset Group
Illinois
$41K +$45.8K +20 New
Deutsche Bank
44
Deutsche Bank
Germany
$40K +$4.58K +2 +18%
Bank of America
45
Bank of America
North Carolina
$39K -$13.7K -6 -32%
JP Morgan Chase
46
JP Morgan Chase
New York
$37K – – –
Legal & General Group
47
Legal & General Group
United Kingdom
$24K +$4.58K +2 +33%
Citigroup
48
Citigroup
New York
$24K +$11.4K +5 +167%
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
$18K +$4.58K +2 +50%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$16.1K +$2.29K +1 +25%
1
2
3

MBIO Hedge Fund Activity: Q4 2019 in Review

55 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2019, worth a combined $35.8M — up 1.4% from $35.3M a quarter earlier.

Fund positioning in MBIO was balanced in Q4 2019: 7 funds opened new positions, 7 closed out, 22 added to existing stakes and 11 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $769K. The largest seller was Consonance Capital Management, exiting entirely with an estimated $10.3M sold.

  • 55 institutional investors held Mustang Bio (MBIO) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $35.8M of Mustang Bio stock for Q4 2019, up 1.4% quarter-over-quarter.
  • 7 funds opened new Mustang Bio positions in Q4 2019 and 7 closed out, a net change of 0 holders.
  • The largest Mustang Bio buyer in Q4 2019 was OrbiMed, an estimated $769K added.
  • The largest Mustang Bio seller in Q4 2019 was Consonance Capital Management, an estimated $10.3M sold.

Based on aggregated 13F filings for Q4 2019.